Deborah Dunsire - Director at Syros Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SYRS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Deborah Dunsire since 7/7/2023

Holdings reported by Deborah Dunsire for Syros Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 12,000 $59.4 K $4.95 Jun 1, 2024 Direct
Restricted Stock Units 4,000 $19.8 K $4.95 Jun 5, 2024 Direct Common Stock
Stock Option (right to buy) 6,000 Jun 5, 2024 Direct Common Stock

Transactions reported by Deborah Dunsire for Syros Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership